1. Introduction {#sec0005}
===============

Desmoids are rare tumors, and the estimated incidence is reported to be 2--4 per million population per year \[[@bib0005]\]. Although desmoids lack the potential for distant metastases, desmoid tumors are locally aggressive and can destroy vital organs, especially intra-abdominal desmoids that often result in fatal outcomes \[[@bib0010]\]. Most desmoid tumors are asymptomatic unless the destruction of organs has occurred. It is known that about 30 percent of patients with desmoids have an antecedent trauma, particularly a surgical intervention for familial adenomatous polyposis (FAP) \[[@bib0015], [@bib0020], [@bib0025]\]. However, cases of mesenteric desmoid after gastrectomy for gastric cancer are extremely rare, and there have been few reports in the literature \[[@bib0030], [@bib0035], [@bib0040], [@bib0045]\]. We present a case of multiple mesenteric desmoids after total gastrectomy for gastric cancer with a review of the relevant literature in line with the SCARE criteria \[[@bib0050]\].

2. Presentation of case {#sec0010}
=======================

A 70-year-old Asian man had undergone total gastrectomy for a gastric cancer, and a Roux-en-Y esophagojejunostomy was performed. Histological examination of the tumor showed moderately differentiated tubular adenocarcinoma, and the tumor was classified as pT1N0M0, stage IA according to the Union for International Cancer Control classification, 7th edition. He had an uneventful postoperative course. He had no other medical history or family history. One year post-gastrectomy, he was asymptomatic, but the CT showed three mesenteric masses (0.5 cm, 2.5 cm and 1 cm in diameter). Based on mutual agreement with the patient that he required monitoring, we performed careful observation without surgical resection or chemotherapy. Then, the 2-year postoperative CT indicated slowly growing masses (1.5 cm, 4 cm and 1.5 cm in diameter, as shown in [Fig. 1](#fig0005){ref-type="fig"}). The tumor marker levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) had been within normal limits. Positron emission tomography (PET) revealed fluorodeoxyglucose (FDG) uptake of two masses, and the maximum standard uptake value (SUVmax) of the largest mass was 4.1 ([Fig. 2](#fig0010){ref-type="fig"}). There were no swollen lymph nodes, and there was neither ascites nor other distant metastases. We firstly suspected relapse of the gastric cancer; however, the recurrence was uncertain, and the possibility of another tumor was suspected because the gastric cancer had been diagnosed at a very early stage, the growth speed of the masses was leisurely and the number of masses was not increased. Therefore, we decided to perform a diagnostic operation to determine the tumor type.Fig. 1CT showing 3 enhanced, round-shaped masses mimicking gastric cancer lymph nodes or peritoneal dissemination recurrence that increased in size but not in number. Small characters indicate the CT a year after gastrectomy, and large characters indicate the CT two years after gastrectomy. a: 0.5 cm, b: 2.5 cm, c: 1.0 cm in diameter. A: 1.5 cm, B: 4 cm, C: 1.5 cm in diameter.Fig. 1Fig. 2Positron emission tomography revealing FDG uptake of two masses, although one mass did not take up FDG. a: A small mass with mild uptake of FDG, b: a large mass with uptake of FDG; the maximum standard uptake value of 4.1, c: a small mass without uptake of FDG.Fig. 2

We continuously performed a laparotomy to resect and survey the masses. There were three mesenteric masses near the bowel: a 1.5-cm diameter mass, 20 cm distal from the jejunojejunostomy; a 4-cm diameter mass, 80 cm distant from the jejunojejunostomy, and a 1.5-cm diameter mass, 120 cm distant from the jejunojejunostomy ([Fig. 3](#fig0015){ref-type="fig"}). We performed partial small intestinal resections for each mass. Histological examination showed desmoid tumors that were 15 × 12 mm, 40 × 40 mm and 15 × 13 mm ([Fig. 4](#fig0020){ref-type="fig"}). Immunology testing indicated β-catenin (+). The patient had an uneventful postoperative course. A year after surgery, he was doing well with no evidence of recurrence of the desmoid tumors or the gastric cancer.Fig. 3Intraoperative pictures showing 3 masses of the jejunal mesentery close to the jejunum. a: 3-cm mass mimicking peritoneal dissemination, 20 cm from the jejunojejunostomy, b: a 4-cm round mass with a pellicle, 80 cm from the jejunojejunostomy, and a 1.5-cm mass mimicking peritoneal dissemination, 120 cm from the jejunojejunostomy.Fig. 3Fig. 4a: Gross appearance of the largest mesenteric desmoid tumor that was resected with negative surgical margins. b: Histological examination revealing spindle-shaped cells and collagen fibers (hematoxylin and eosin stain). c: Immunostaining showing diffuse β-catenin positive.Fig. 4

3. Discussion {#sec0015}
=============

Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer. Typically, a desmoid tumor is solitary and occurs at the extremities or abdominal wall in premenopausal woman or at the surgical site in patients with FAP \[[@bib0055], [@bib0060], [@bib0065]\]. It was reported that about 50 percent of all desmoid tumors are intra-abdominal, but cases in patients without FAP accounted for only about 10 percent \[[@bib0005],[@bib0070]\]. Although rare, there are some reports of multiple mesenteric desmoids that were difficult to distinguish from the recurrence of malignancy \[[@bib0045],[@bib0075],[@bib0080]\]. We found six cases of intra-abdominal desmoid tumor after gastrectomy for gastric cancer ([Table 1](#tbl0005){ref-type="table"}) \[[@bib0030], [@bib0035], [@bib0040], [@bib0045]\]. Moreover, two of six cases including our case manifested multiple mesenteric tumors. The diagnostic difficulty would remain unrecognized due to the wrong diagnosis of gastric cancer recurrence, and as matter of fact, in two of six reported cases, chemotherapy had been performed prior to the surgical resection. Therefore, we presumed that there could be more hidden desmoid cases. We should be aware that desmoid could manifest as multiple mesenteric tumors after gastrectomy for gastric cancer.Table 1Desmoid tumors after gastrectomy for gastric cancer.Table 1AuthorAgeSexAntecedent gastrectomyPathology (adeno- carcinoma)StageDuration (months)Size (mm)SUVmax of PETTumor markersSites of mesenteryInitial diagnosisTreatmentRecurrenceKomatsu et al.50MTotalWellT3N0M0, stage IIA1250\*\*Jejunum\*RecurrenceChemotherapy \> OperationNoTamura et al.73FTotal\*T1N0M0, stage IA2463\*NormalJejunal pouch\*OperationNoOkamura et al.57MDistalPoorlyT2N0M0, stage IB27403.9ElevatedTransverse colonRecurrenceChemotherapy \> OperationNoKim et al.50MDistalPoorlyT1N1M0, stage IB2450, 60\*\*Jejunum nearby and 100-cm distal from gastrojejunostomyRecurrence or Benign tumorOperationNoKim et al.60MTotalMucinousT2N2M0, stage IIB2360Mild\*Ileum 30-cm proximal from ileocecal valveRecurrenceOperationNoOur case70MTotalModeratelyT1N0M0, stage IA1215, 40, 154.1NormalJejunum 20-cm distal and 80-cm distal and 120-cm distal from jejunojejunostomyRecurrence or Benign tumorOperationNo[^1][^2]

Surgical resection of the tumors could be a useful diagnostic and treatment option in this setting. Diagnosing intra-abdominal desmoids is often difficult. In this case, the desmoids did not have a specific feature on CT, which showed an enhanced round-shaped mass mimicking gastric cancer lymph nodes or peritoneal dissemination recurrence \[[@bib0030], [@bib0035], [@bib0040], [@bib0045]\]. The desmoids had mild uptake of FDG on PET, and the SUVmax did not allow us to make a differential diagnosis between a desmoid and a recurrence of the gastric cancer \[[@bib0040],[@bib0045]\]. Tumor marker levels might help us to distinguish a desmoid tumor from the recurrence of gastric cancer. Although CEA is often elevated in a case of gastric cancer recurrence, it is not relevant for desmoid tumors; nevertheless, a case of desmoid tumor with cryptogenic elevation of serum CEA levels was reported \[[@bib0040]\]. Thus, the diagnosis of desmoid tumors can be established only by histological examination of the biopsy specimen. However, core needle biopsy of an intra-abdominal tumor has a risk of dissemination. Moreover, if a patient has a prior history of malignancy, it may be extremely difficult to differentiate between multiple mesenteric desmoids and disease recurrence. Because desmoid tumors lack metastatic potential, treatment strategies for these tumors are careful observation or local therapies \[[@bib0085], [@bib0090], [@bib0095], [@bib0100]\]. On the other hand, most cancer recurrences would be treated with systemic therapy, but a metastasectomy is hardly indicated, especially in cases with multiple metastatic masses. In terms of the treatment strategy, there is a big difference between these two diagnoses. Therefore, differential diagnosis is very important, but it remains difficult to distinguish multiple mesenteric desmoid tumors from a cancer recurrence preoperatively. We elucidated that the surgical resection is, if technically possible, a useful option as diagnostic therapy. Further reports should be accumulated about the preoperative differentiation between multiple mesenteric desmoid tumors and disease recurrence.

Although the differential diagnosis of multiple mesenteric desmoid tumors was difficult, it was evident that the treatment plan should be decided based on the diagnostic imaging. In general, initial careful observation seemed to be an acceptable treatment option for asymptomatic desmoids, whereas surgical resection with negative surgical margins was the feasible treatment when it was technically practicable \[[@bib0085], [@bib0090], [@bib0095], [@bib0100]\]. In cases with an antecedent malignancy, however, a recurrence of that cancer should be excluded, especially for the observation strategy. In our case, we considered the possibility of primary mesenteric tumors for the following reasons: the original gastric cancer was early stage; the three masses were on the mesentery, distant from the previous surgical site without regional lymph node swelling; the masses increased in size but not in number; ascites was never seen; and the tumor marker levels had been within normal limits. Additionally, we considered those three tumors resectable on the diagnostic imaging. Taken together, these factors led us to perform surgical resection as diagnostic therapy.

4. Conclusions {#sec0020}
==============

Multiple mesenteric desmoids could emerge after gastrectomy for gastric cancer. If a patient has an antecedent history of malignancy, it may be extremely difficult to differentiate between multiple mesenteric desmoids and disease recurrence. In terms of the treatment strategy, there is a big difference between the two diagnoses. We stressed that the surgical resection was, if technically practicable, a useful treatment option as diagnostic therapy.
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[^1]: PET: positron emission tomography; SUVmax: maximum standard uptake value.
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